Mersana Therapeutics (NASDAQ: MRSN ) is an early phase biotech that has faced challenges in recent years, having shelved several once-promising clinical candidates. In my first outing on the company, I suggested that theyI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitf ...